The clinical and molecular effects of an insulin sensitizing drug 'pioglitazone' on treatment of psoriasis / Vanessa Suzan Galal Aly Hafez ; Supervised Manal A. W. Bosseila , Mohamed I. Sheta , Mona R. E. Abdelhalim
Material type:
- المفعول الإكلينيكي و الجزيئي للدواء المحسس الانسولين "بيوجليتازون" في علاج الصدفية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.10.Ph.D.2011.Va.C (Browse shelf(Opens below)) | Not for loan | 01010110055693000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.10.Ph.D.2011.Va.C (Browse shelf(Opens below)) | 55693.CD | Not for loan | 01020110055693000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
Psoriasis has been viewed recently as a multisystem disease with several important comorbidities such as: metabolic symdrome, insulin resistance and increased cardiovascular risk. All share common inflammatory pathogenic mechanisms. Pioglitazone, a peroxisome proliferator activated receptor-gamma (PPAR y) agonist
Issued also as CD
There are no comments on this title.